The shingles project is the third vaccine collaboration between the two companies, as they began an influenza vaccine collaboration in 2018 and a COVID-19 vaccine collaboration in 2020, according to a Jan. 5 news release.
The vaccine will be based on BioNTech’s mRNA platform and Pfizer’s antigen technology, the companies said. Under the deal, Pfizer will pay BioNTech $225 million and BioNTech will pay Pfizer $25 million.
The companies expect clinical trials to begin in the second half of 2022.
Read more about the collaboration here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
